Daily ReportNov 3, 2026
Sepsis, November 3 edition
We read 39 papers and selected 3.
Summary
Today’s most impactful sepsis research spans a novel metabolic–inflammatory mechanism, long-term cardiovascular consequences, and molecular immune endotyping. The leading mechanistic study identifies HSC70 lactylation as a potentially actionable driver of chaperone-mediated autophagy failure and PANoptosis, while a large prospective cohort demonstrates that severe infection is associated with both acute and persistent excess arrhythmia risk.
Research Themes
- Metabolic regulation of macrophage PANoptosis
- Long-term cardiovascular sequelae after severe infection
- Molecular stratification of sepsis immune endotypes
Selected Articles
1. Lactylation of HSC70 Impairs Chaperone-Mediated Autophagy to Promote Pyrin Inflammasome-Dependent PANoptosis in Macrophages During Sepsis.
This mechanistic study identifies a feedback loop linking inflammatory signaling, impaired chaperone-mediated autophagy, and macrophage PANoptosis during sepsis. Lactylation of HSC70 at lysine 561 reduced autophagy activity, increased CUX1 and Pyrin expression, and promoted Pyrin-mediated PANoptosome assembly; enhancing autophagy or blocking lactylation attenuated macrophage death and organ injury.
Impact: The study provides a novel mechanistic link between immunometabolic reprogramming and inflammatory cell death, identifying the Kla–CMA–CUX1/Pyrin–PANoptosis axis as a potential therapeutic target. Its value is primarily translational and mechanistic; clinical efficacy remains untested.
Clinical Implications: The findings support future development of therapies that modulate HSC70 lactylation, chaperone-mediated autophagy, or Pyrin inflammasome signaling in selected septic patients. Translation will require pharmacologic specificity, toxicity testing, and validation in clinically representative models.
Key Findings
- IFNγ/LPS-induced inflammation established a positive feedback loop between impaired chaperone-mediated autophagy and macrophage PANoptosis.
- HSC70 lactylation at lysine 561 was associated with reduced autophagy activity and enhanced CUX1/Pyrin-dependent PANoptosome assembly.
- Enhancing chaperone-mediated autophagy or blocking HSC70 lactylation reduced macrophage death and sepsis-associated multiple-organ injury.
Methodological Strengths
- The study connects molecular modification, autophagy regulation, inflammasome assembly, cell death, and organ injury across mechanistic levels.
- Both pathway activation and inhibition experiments support the proposed causal signaling axis.
Limitations
- The abstract does not establish whether the intervention is effective in human sepsis.
- The therapeutic window, cell-type specificity, and potential toxicity of manipulating lactylation or autophagy remain uncertain.
Future Directions: Future studies should validate the Kla–CMA–CUX1/Pyrin axis in multiple in vivo sepsis models and human biospecimens, define biomarkers for patient selection, and develop selective inhibitors or activators with favorable pharmacokinetics.
Sepsis-related cytokine storm is associated with poor prognosis in septic patients. IFNγ/LPS can synergistically trigger a sepsis-associated proinflammatory cytokine storm and induce macrophage death in the form of PANoptosis. The ensuing release of proinflammatory cytokines further amplifies macrophage death, leading to subsequent multiple organ damage. Concurrently, the IFNγ/LPS induced inflammatory cascade also downregulates chaperone-mediated autophagy (CMA) activity, and this dysregulation further exacerbates the inflammatory response in macrophages and in vivo. Thus, a positive feedback loop between dysfunctional CMA and the inflammatory cascade is established.
2. Temporal associations between severe infection and long-term risk of incident arrhythmias: a population-based cohort study.
In a prospective population-based analysis of 465,374 UK Biobank participants, severe infection was associated with increased risk of incident arrhythmias across multiple rhythm disorders. Risk was highest during days 1–30, but remained elevated beyond one year; sepsis conferred the greatest risk among infection types, recurrent infections showed a dose-response pattern, and associations were externally validated in ARIC and CHS cohorts.
Impact: This study broadens the recognized sequelae of severe infection from short-term organ dysfunction to clinically important long-term electrical cardiac disease. Its large sample, time-dependent analysis, and external validation provide a strong epidemiological basis for post-infection cardiovascular risk assessment.
Clinical Implications: Clinicians may consider severe infection, particularly sepsis and recurrent infection, as an additional factor when assessing arrhythmia risk during early recovery and subsequent follow-up. The findings do not yet establish that routine rhythm screening improves outcomes or should be universally implemented.
Key Findings
- Severe infection was associated with incident arrhythmia risk, with an adjusted hazard ratio of 1.85 for any arrhythmia.
- The strongest associations involved ventricular arrhythmias, sudden cardiac arrest, and atrioventricular block.
- Risk peaked within 1–30 days after infection but remained elevated beyond 366 days; recurrent infections produced greater risk than first infections.
- The associations were validated in ARIC and CHS cohorts.
Methodological Strengths
- The study included a very large prospective population and detailed time-dependent exposure analyses.
- Models adjusted for sociodemographic, lifestyle, clinical, and biochemical factors, with external validation in two independent cohorts.
Limitations
- The observational design cannot establish that severe infection causes arrhythmias.
- Residual confounding, misclassification of infection severity, and differences in healthcare access or post-infection monitoring may influence the associations.
- The study does not test whether targeted arrhythmia screening or preventive treatment improves clinical outcomes.
Future Directions: Future research should investigate biological mechanisms linking infection to electrical cardiac remodeling and evaluate risk-guided electrocardiographic monitoring, ambulatory rhythm assessment, and preventive strategies in high-risk survivors.
BACKGROUND: The long-term impact of severe infection on arrhythmia risk across the cardiac rhythm spectrum remains incompletely characterized. We investigated the association between hospital-treated infection and incident arrhythmias, examining temporal patterns, pathogen and site specificity, and cumulative effects. METHODS: We conducted a prospective analysis of 465,374 UK Biobank participants. Time-dependent Cox proportional hazards models were adjusted for sociodemographic factors, lifestyle behaviors, clinical comorbidities, and biochemical parameters. Comprehensive analyses assessed infection timing (1-30, 31-365, ≥366 days), type (bacterial, viral, sepsis), site, and recurrence. Findings were validated in ARIC and CHS cohorts. RESULTS: Over a median follow-up of 14.2 years, 70,527 (15.2%) participants had a severe infection.
3. Distinct transcriptomic signatures discriminate hyperinflammation from immune paralysis in sepsis: a single-cell RNA sequencing study.
This single-cell transcriptomic study distinguishes macrophage activation-like syndrome (MALS) from immune paralysis primarily through divergent monocyte transcriptional programs. MALS-specific monocyte clusters and a sepsis-specific vulnerability-associated cluster were identified, and the findings were validated in two independent cohorts, supporting molecular stratification for precision immunotherapy.
Impact: The study addresses a major reason for failed sepsis immunotherapy: biological heterogeneity among patients. By connecting clinically defined immune endotypes to single-cell monocyte programs and independent validation, it provides a practical foundation for biomarker-guided therapeutic trials.
Clinical Implications: The findings support measuring immune endotypes rather than applying uniform immunomodulation to all patients with sepsis. The transcriptomic signatures may guide future trials of immunostimulatory or anti-inflammatory treatments, but they are not yet validated as bedside decision tools.
Key Findings
- Monocyte transcriptional programs clearly distinguished MALS from immune paralysis in sepsis.
- Unsupervised clustering identified MALS-specific monocyte clusters and a sepsis-specific cluster associated with greater comorbidity burden and clinical vulnerability.
- The molecular patterns were reproduced in two independent cohorts, and MALS-associated signatures overlapped with those observed in severe COVID-19.
Methodological Strengths
- Single-cell RNA sequencing provided cell-type-resolved analysis of circulating immune responses.
- The study linked molecular signatures to clinically defined immune endotypes and performed validation in two independent cohorts.
Limitations
- The discovery cohort was small, including 16 sepsis patients and 6 healthy controls.
- Endotype classification relied on surrogate biomarkers, and the transcriptomic signatures were not prospectively tested for treatment selection.
- The study establishes association rather than proving that the identified cell states cause organ dysfunction or treatment response.
Future Directions: Prospective multicenter studies should test rapid endotype assays, determine temporal stability during sepsis, and evaluate whether biomarker-guided immunotherapy improves patient-centered outcomes.
BACKGROUND: Sepsis is a highly heterogeneous syndrome characterized by variable immune dysregulation states, including hyperinflammation and immunosuppression. Previous immunotherapy attempts in sepsis have largely failed, likely due to a "one-size-fits-all" approach that ignores each patient's immune status. The recent ImmunoSep randomized clinical trial demonstrated that precision immunotherapy guided by the presence of either macrophage activation-like syndrome (MALS) or immune paralysis can improve early organ dysfunction in sepsis patients. However, the molecular mechanisms underlying these immune endotypes remain unclear. OBJECTIVES: To identify the immunological signatures that distinguish MALS and immune paralysis. METHODS: We used single-cell RNA sequencing to profile circulating leukocytes of 6 healthy controls and 16 sepsis patients classified as MALS, immune paralysis or unclassified (when criteria for neither of these two immune endotypes were applicable).